Market Overview

Roth Capital Maintains Buy on Cell Therapeutics, Inc., Raises PT to $6.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for CTIC

DateFirmActionFromTo
Sep 2014Piper JaffrayInitiates Coverage onOverweight
Aug 2014Wallachbeth CapitalUpgradesHoldBuy
May 2014Ladenburg ThalmannInitiates Coverage onBuy

View More Analyst Ratings for CTIC
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (CTIC)

Around the Web, We're Loving...

Get Benzinga's Newsletters